| Expert Opinion on Biological Therapy | |
| Discipline: | Therapeutics |
| Abbreviation: | Expert Opin. Biol. Ther. |
| Editor: | Michael Morse |
| Publisher: | Taylor & Francis |
| History: | 2001-present |
| Frequency: | Monthly |
| Impact: | 3.974 |
| Impact-Year: | 2017 |
| Website: | http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=iebt20 |
| Link1: | http://www.tandfonline.com/toc/iebt20/current |
| Link1-Name: | Online access |
| Link2: | http://www.tandfonline.com/loi/iebt20 |
| Link2-Name: | Online archive |
| Issn: | 1471-2598 |
| Eissn: | 1744-7682 |
| Lccn: | 2001243388 |
| Oclc: | 48476209 |
Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse (Duke University Hospital). The journal was established in 2001 and according to the Journal Citation Reports, it has a 2017 impact factor of 3.974.[1] The journal is also indexed in MEDLINE.